Vistin Pharma ASA (OSL:VISTN)

Vistin Pharma ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	878	1,051	1,033	701	859	774
Market Cap Growth	-18.18%	1.72%	47.47%	-18.47%	11.06%	67.79%
Enterprise Value	897	1,053	1,034	739	809	678
Last Close Price	19.80	22.55	20.61	13.97	17.14	15.11
PE Ratio	11.25	16.75	22.66	-	34.56	-
Forward PE	-	9.45	9.45	9.45	9.45	9.45
PS Ratio	1.93	2.45	2.36	2.30	3.08	3.05
PB Ratio	2.81	3.40	3.20	2.56	3.12	2.84
P/TBV Ratio	2.81	3.40	3.20	2.56	3.12	2.84
P/FCF Ratio	13.53	15.67	14.21	-	-	-
P/OCF Ratio	11.02	9.74	11.41	-	62.82	-
PEG Ratio	-	1.72	1.72	1.72	1.72	1.72
EV/Sales Ratio	1.97	2.45	2.36	2.43	2.90	2.67
EV/EBITDA Ratio	7.72	10.20	12.19	138.71	18.91	12.49
EV/EBIT Ratio	9.48	12.35	15.08	-	24.34	14.89
EV/FCF Ratio	13.83	15.71	14.23	-	-	-
Debt / Equity Ratio	0.07	0.00	-	0.18	0.01	-
Debt / EBITDA Ratio	0.20	0.01	-	7.95	0.03	-
Debt / FCF Ratio	0.35	0.02	-	-	-	-
Asset Turnover	1.12	1.09	1.08	0.82	0.85	0.62
Inventory Turnover	1.87	1.91	2.16	2.19	2.57	2.62
Quick Ratio	1.16	1.01	1.24	0.62	1.92	3.38
Current Ratio	2.23	2.24	2.43	1.35	3.36	4.39
Return on Equity (ROE)	25.04%	19.85%	15.29%	-1.72%	9.07%	-28.27%
Return on Assets (ROA)	14.56%	13.53%	10.58%	-1.03%	6.35%	6.89%
Return on Capital (ROIC)	18.09%	16.83%	13.29%	-1.27%	7.56%	8.27%
Return on Capital Employed (ROCE)	27.80%	26.60%	20.50%	-2.10%	11.40%	15.70%
Earnings Yield	8.89%	5.97%	4.41%	-0.67%	2.89%	-12.53%
FCF Yield	7.39%	6.38%	7.03%	-10.68%	-2.13%	-25.70%
Dividend Yield	6.25%	5.54%	4.85%	5.37%	4.38%	3.31%
Payout Ratio	99.42%	123.65%	-	-	89.17%	-
Total Shareholder Return	6.25%	5.54%	4.85%	5.37%	4.38%	3.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.